If you suspect you are experiencing side effects from Mounjaro, you or your healthcare professional can report these to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk), which helps monitor the safety of medicines
Other Common (1% to 10%): Fatigue, including asthenia, malaise, lethargy Uncommon (0.1% to 1%): Blood calcitonin increased Renal Postmarketing reports (in other GLP-1 receptor agonists): Acute kidney injury, worsening of chronic renal failure Respiratory Very common (10% or more): Nasopharyngitis (10.5%) References 1
Clean the vial stopper and skin with alcohol
Some protocols divide the weekly dose into two smaller injections, which can smooth out side effects while also giving you more flexibility in timing doses around your BUD
If regulatory approval, prescription access, and insurance coverage matter, tirzepatide is the only option